CEO
BioCardia
Sunnyvale, California, United States
Peter A. Altman, Ph.D. FAHA has served as BioCardia CEO since 2002, where he is focused on cell and gene therapies for heart failure, chronic myocardial ischema, and acite infarction. He was founding CEO of CareDx, a developer of a gene based diagnostics to be used in chronic inflammatory diseases, including cardiac transplantation. He received his Ph.D. from the UCSF/UCB, his MOT from the Haas School of Business, and his MS and BS from the Columbia University. He is named inventor in >50 U.S. patents, and has authored >40 scientific publications.
Disclosure information not submitted.